Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Chaigui Tuire Koufuye, also known as Xiaoer Chaigui antipyretic oral liquid, is a traditional Chinese medicine (TCM) preparation used for pediatric patients. [11] Its primary indication is for fever resulting from an external contraction, with symptoms including fever, headache, body aches, runny nose, thirst, and red throat. [3] The formulation is based on classic TCM prescriptions and is designed to induce sweating to relieve the exterior syndrome while also clearing internal heat. [5, 13] It is composed of several herbs, including Bupleurum (Chai Hu), Cassia Twig (Gui Zhi), Kudzu Root (Ge Gen), and others. [2, 4] The medicine is manufactured by companies such as Jilin Aodong Yanbian Pharmaceutical Co., Ltd. [2, 9] While it has antipyretic effects, particularly for low-grade fevers, it is not considered a direct substitute for Western antipyretic drugs like ibuprofen or acetaminophen, especially in cases of high fever (above 38.5°C). [5, 8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer chaigui tuire koufuye.